These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28526528)

  • 1. Gluten-degrading bacteria are present in the human small intestine of healthy volunteers and celiac patients.
    Herrán AR; Pérez-Andrés J; Caminero A; Nistal E; Vivas S; Ruiz de Morales JM; Casqueiro J
    Res Microbiol; 2017 Sep; 168(7):673-684. PubMed ID: 28526528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease.
    Caminero A; Herrán AR; Nistal E; Pérez-Andrés J; Vaquero L; Vivas S; Ruiz de Morales JM; Albillos SM; Casqueiro J
    FEMS Microbiol Ecol; 2014 May; 88(2):309-19. PubMed ID: 24499426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
    Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ
    Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.
    Caminero A; Galipeau HJ; McCarville JL; Johnston CW; Bernier SP; Russell AK; Jury J; Herran AR; Casqueiro J; Tye-Din JA; Surette MG; Magarvey NA; Schuppan D; Verdu EF
    Gastroenterology; 2016 Oct; 151(4):670-83. PubMed ID: 27373514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.
    Duar RM; Clark KJ; Patil PB; Hernández C; Brüning S; Burkey TE; Madayiputhiya N; Taylor SL; Walter J
    J Appl Microbiol; 2015 Feb; 118(2):515-27. PubMed ID: 25376327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of Gut-Resistant Bacteria and Construction of Microbial Consortia for Improving Gluten Digestion under Simulated Gastrointestinal Conditions.
    De Angelis M; Siragusa S; Vacca M; Di Cagno R; Cristofori F; Schwarm M; Pelzer S; Flügel M; Speckmann B; Francavilla R; Gobbetti M
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Insights into the Gut Microbiota of Mexican Patients with Celiac Disease and Non-Celiac Gluten Sensitivity.
    Garcia-Mazcorro JF; Rivera-Gutierrez X; Cobos-Quevedo OJ; Grube-Pagola P; Meixueiro-Daza A; Hernandez-Flores K; Cabrera-Jorge FJ; Vivanco-Cid H; Dowd SE; Remes-Troche JM
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in lactobacilli in the intestinal microbiota of celiac children with a gluten-free diet, and selection of potentially probiotic strains.
    Lorenzo Pisarello MJ; Vintiñi EO; González SN; Pagani F; Medina MS
    Can J Microbiol; 2015 Jan; 61(1):32-7. PubMed ID: 25438612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human digestive tract has proteases capable of gluten hydrolysis.
    Gutiérrez S; Pérez-Andrés J; Martínez-Blanco H; Ferrero MA; Vaquero L; Vivas S; Casqueiro J; Rodríguez-Aparicio LB
    Mol Metab; 2017 Jul; 6(7):693-702. PubMed ID: 28702325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary and fecal microbiota and metabolome of celiac children under gluten-free diet.
    De Angelis M; Vannini L; Di Cagno R; Cavallo N; Minervini F; Francavilla R; Ercolini D; Gobbetti M
    Int J Food Microbiol; 2016 Dec; 239():125-132. PubMed ID: 27452636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human small-intestinal gluten-degrading bacteria and its potential implication in celiac disease.
    Dewala S; Bodkhe R; Nimonkar Y; Prakash OM; Ahuja V; Makharia GK; Shouche YS
    J Biosci; 2023; 48():. PubMed ID: 37309172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel probiotic preparation with
    Nikoloudaki O; Celano G; Polo A; Cappello C; Granehäll L; Costantini A; Vacca M; Speckmann B; Di Cagno R; Francavilla R; De Angelis M; Gobbetti M
    Microbiol Spectr; 2024 Jul; 12(7):e0352423. PubMed ID: 38860826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, Perceived Intestinal Well-Being and Compositions of Fecal Microbiota and Short Chain Fatty Acids in Oat-Using Subjects with Celiac Disease or Gluten Sensitivity.
    Nylund L; Hakkola S; Lahti L; Salminen S; Kalliomäki M; Yang B; Linderborg KM
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Barrier Function in Gluten-Related Disorders.
    Cardoso-Silva D; Delbue D; Itzlinger A; Moerkens R; Withoff S; Branchi F; Schumann M
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31581491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease.
    Bascuñán KA; Araya M; Roncoroni L; Doneda L; Elli L
    Adv Nutr; 2020 Jan; 11(1):160-174. PubMed ID: 31399743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease.
    Freire R; Ingano L; Serena G; Cetinbas M; Anselmo A; Sapone A; Sadreyev RI; Fasano A; Senger S
    Sci Rep; 2019 May; 9(1):7029. PubMed ID: 31065051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives.
    Caminero A; Nistal E; Herrán AR; Pérez-Andrés J; Ferrero MA; Vaquero Ayala L; Vivas S; Ruiz de Morales JM; Albillos SM; Casqueiro FJ
    Br J Nutr; 2015 Oct; 114(8):1157-67. PubMed ID: 26428276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active celiac disease vs non-celiac disease controls.
    Nistal E; Caminero A; Herrán AR; Pérez-Andres J; Vivas S; Ruiz de Morales JM; Sáenz de Miera LE; Casqueiro J
    J Appl Microbiol; 2016 Jun; 120(6):1691-700. PubMed ID: 26913982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
    Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
    Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal.
    Tursi A; Brandimarte G; Giorgetti G
    Am J Gastroenterol; 2003 Apr; 98(4):839-43. PubMed ID: 12738465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.